Acetazolamide (Diamox) for Altitude: Should Athletes Use It and What Are the Risks?

A science-based guide to acetazolamide (Diamox) for altitude sickness prevention in athletes — how it works, evidence for efficacy, side effects, and whether it's appropriate for altitude training camp use.

altitude medication AMS acclimatization safety

Acetazolamide (Diamox) for Altitude: Should Athletes Use It and What Are the Risks?

Acetazolamide (brand name Diamox) is the most widely prescribed medication for altitude sickness prevention. Mountaineers and trekkers rely on it routinely. For athletes planning altitude training camps, the question is more nuanced: does acetazolamide help, hurt, or simply have no net effect on altitude training adaptation and performance?

The answer depends on how and why you're using it.

What Is Acetazolamide and How Does It Work?

Acetazolamide is a carbonic anhydrase inhibitor — a class of drug that blocks the enzyme carbonic anhydrase, which catalyzes the conversion of CO₂ and water into bicarbonate and hydrogen ions (and the reverse reaction) in multiple tissues.

At altitude, acetazolamide's relevant mechanism is renal: by inhibiting carbonic anhydrase in the kidney tubules, it prevents bicarbonate reabsorption, increasing bicarbonate excretion in the urine. This causes a mild metabolic acidosis that mimics the bicarbonate compensation that normally takes 3–5 days of acclimatization to develop naturally.

The net effect: The blood becomes mildly more acidic, which removes the suppressive brake on breathing (the hypocapnia/alkalosis that blunts the hypoxic ventilatory response), allowing deeper and more frequent breathing in response to hypoxia. Ventilation increases, SpO₂ rises, and the physiological cascade that produces AMS symptoms is partially short-circuited.

Acetazolamide effectively accelerates ventilatory acclimatization — compressing what normally takes 3–5 days into 1–2 days.

Evidence for AMS Prevention

The evidence that acetazolamide reduces AMS incidence and severity is robust. Multiple randomized controlled trials across multiple decades consistently show:

  • AMS incidence reduction: 50–75% fewer AMS cases compared to placebo in controlled ascent studies
  • Severity reduction: When breakthrough AMS occurs despite acetazolamide, it is typically milder
  • Sleep improvement: Acetazolamide reduces altitude-related periodic breathing, improving sleep quality and SpO₂ during sleep
  • Effective dose: 125 mg twice daily is as effective as 250 mg twice daily with fewer side effects; some evidence supports 62.5 mg twice daily for mild AMS prevention

Standard protocol: start 24–48 hours before ascending to altitude; continue for 2–3 days after arrival (or until acclimatization symptoms resolve).

Potential Concerns for Athletes

Does Acetazolamide Impair Exercise Performance?

This is the question most relevant to athletes, and it's more complex than for recreational trekkers:

Mild metabolic acidosis: Acetazolamide's mechanism causes mild metabolic acidosis. Acidosis impairs muscular performance at high intensities by altering the buffering capacity of working muscle. Studies in athletes using acetazolamide at sea level generally show modest (1–3%) reductions in high-intensity performance.

Reduced CO₂ sensitivity: The drug's effect on carbonic anhydrase in working muscle and red blood cells may slightly impair CO₂ transport and buffering during intense exercise. The practical magnitude of this effect at training altitudes (2,000–2,800 m) is modest.

Diuresis: Acetazolamide increases urine output, which can contribute to dehydration if fluid intake is not compensated.

Net assessment: For AMS prevention and acclimatization acceleration (the intended use cases), the modest performance impairment from acetazolamide during early altitude days is generally outweighed by the benefits of faster acclimatization and better sleep. For athletes whose immediate training quality in days 1–3 at altitude is critical, this tradeoff requires individual consideration.

Does Acetazolamide Blunt Altitude Adaptation?

A more theoretical concern is whether artificially accelerating ventilatory acclimatization reduces the adaptive stimulus for other altitude adaptations (EPO, erythropoiesis). Current evidence does not support this concern:

  • Studies examining hematological markers (EPO, reticulocytes, tHbmass) in athletes using acetazolamide for prophylaxis show comparable gains to non-users
  • The drug targets renal bicarbonate handling, not the HIF/EPO pathway that drives erythropoiesis
  • If anything, improved SpO₂ during sleep (by reducing periodic breathing) increases the cumulative hypoxic dose during sleep hours, potentially supporting rather than blunting erythropoietic adaptation

Side Effects Athletes Should Know About

Tingling in extremities (paresthesia): The most common side effect — typically fingers, toes, and lips. Affects 30–50% of users. Benign but can be distracting during training; typically resolves within 24–48 hours of discontinuing the drug.

Increased urination: Expect increased urine output, especially in the first days of use. Compensate proactively with increased fluid and electrolyte intake.

Taste alteration: Carbonated beverages and some foods taste metallic or unpleasant. Relevant to athletes who rely on carbonated sports drinks or soda for carbohydrate intake.

Sulfa allergy cross-reactivity: Acetazolamide is a sulfonamide-class drug. Athletes with known sulfa allergies should not use it without consultation with a sports physician.

Rare but serious: Stevens-Johnson syndrome (rare severe skin reaction) has been reported with sulfonamide drugs. Discontinue immediately and seek medical attention for any skin rash developing during use.

Who Should Consider Using Acetazolamide for Altitude Training Camps?

Strong case for use:

  • Athletes with a history of significant AMS on prior altitude camps
  • Athletes arriving at high altitude (> 3,000 m) rapidly without an acclimatization period
  • Athletes with important training sessions in days 2–5 at altitude (when AMS risk is highest and prophylaxis provides the most benefit)
  • Athletes arriving with disrupted sleep or illness that may amplify AMS risk

Reasonable case for use:

  • Athletes ascending to 2,500–3,000 m who want to reduce the risk of impaired week-1 training
  • Athletes on very short camps (2 weeks) where every training day counts and AMS would be particularly costly

Weaker case for use:

  • Well-acclimatized athletes returning to a familiar altitude within 4–6 weeks of prior exposure
  • Athletes ascending to < 2,000 m (AMS risk is low; pharmacological prophylaxis adds little benefit)
  • Athletes whose performance profile is highly sensitive to any degree of metabolic acidosis (very high-intensity events)

How to Use Acetazolamide as an Athlete

Dose: 125 mg twice daily is the standard starting point. Some sports medicine physicians recommend 62.5 mg (half a 125 mg tablet) twice daily for mild prophylaxis with minimal side effects.

Timing: Begin 24 hours before ascent; continue for 2–3 days post-arrival or until acute AMS symptoms have resolved.

Duration: Not intended for prolonged use throughout an altitude camp. The goal is to bridge the most vulnerable acclimatization window (days 1–5); natural acclimatization proceeds normally after this period.

Hydration: Increase fluid intake by 500 mL/day above normal altitude targets to compensate for the diuretic effect.

Prescription requirement: Acetazolamide is a prescription medication in most countries. Obtain a prescription from your sports medicine physician well before the camp — don't arrive at altitude without it if you've determined you need it.

Not a substitute for proper acclimatization: Acetazolamide speeds ventilatory acclimatization but does not replace the need for reduced training load in the first days at altitude. Athletes who use acetazolamide and then train at full intensity in days 1–3 still accumulate excessive fatigue — the drug does not prevent training overload, only AMS symptoms.

WADA Status

As of current WADA prohibited list guidelines, acetazolamide is not prohibited in sport. It is not listed on the World Anti-Doping Agency Prohibited List and does not require a Therapeutic Use Exemption (TUE). Athletes should verify the current list independently before use, as prohibited lists are updated annually.

Practical Takeaways

  • Acetazolamide works by accelerating ventilatory acclimatization — it is the most evidence-supported AMS prevention medication available.
  • Standard athlete dose: 125 mg twice daily, starting 24 hours before altitude arrival, for 2–3 days post-arrival.
  • Does not blunt EPO or erythropoietic adaptation — hematological altitude gains are not impaired.
  • May modestly impair high-intensity performance through mild metabolic acidosis — the tradeoff is generally favorable for AMS prevention and sleep improvement.
  • Not prohibited by WADA (verify current list before use).
  • Side effects: tingling extremities (common, benign), increased urination (compensate with fluids), taste changes (benign).
  • Contraindicated in sulfa allergy — check allergy history before use.
  • Prescription required in most countries — obtain from sports medicine physician before departure.
  • Not a substitute for load management — reduce training intensity in days 1–3 regardless of whether you use acetazolamide.

Heading to altitude? Subscribe to the AltitudePerformanceLab newsletter for our free Altitude Health and Safety Protocol — AMS prevention strategies, acclimatization monitoring, and medical guidelines for athletes preparing for high-altitude camps.